Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Forecasted to Post Q2 2024 Earnings of $0.92 Per Share

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Analysts at Leerink Partnrs lowered their Q2 2024 EPS estimates for shares of Acadia Healthcare in a research note issued on Thursday, May 2nd. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of $0.92 for the quarter, down from their previous estimate of $0.96. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.56 per share. Leerink Partnrs also issued estimates for Acadia Healthcare's Q3 2024 earnings at $0.98 EPS, Q4 2024 earnings at $0.86 EPS, FY2024 earnings at $3.59 EPS, Q1 2025 earnings at $0.89 EPS, Q2 2025 earnings at $1.04 EPS, Q3 2025 earnings at $1.09 EPS, Q4 2025 earnings at $0.97 EPS, FY2025 earnings at $4.00 EPS, FY2026 earnings at $4.61 EPS and FY2027 earnings at $5.31 EPS.

Several other equities research analysts also recently weighed in on ACHC. Bank of America decreased their price target on shares of Acadia Healthcare from $105.00 to $90.00 and set a "buy" rating for the company in a research note on Thursday. StockNews.com downgraded Acadia Healthcare from a "hold" rating to a "sell" rating in a report on Friday. TheStreet upgraded Acadia Healthcare from a "c" rating to a "b-" rating in a report on Monday, March 4th. UBS Group boosted their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a "buy" rating in a research note on Wednesday, February 28th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, March 5th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $88.89.

Acadia Healthcare Trading Up 2.5 %

Shares of NASDAQ:ACHC traded up $1.66 during mid-day trading on Monday, hitting $67.78. The company had a trading volume of 1,522,414 shares, compared to its average volume of 615,446. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. Acadia Healthcare has a one year low of $64.74 and a one year high of $87.77. The firm has a fifty day moving average price of $76.77 and a 200 day moving average price of $77.52. The company has a market capitalization of $6.29 billion, a PE ratio of -484.11, a price-to-earnings-growth ratio of 1.96 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The firm had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. During the same period last year, the company posted $0.75 EPS. The business's quarterly revenue was up 9.1% on a year-over-year basis.

Insiders Place Their Bets

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors have recently bought and sold shares of the company. Avidity Partners Management LP increased its stake in shares of Acadia Healthcare by 61.8% in the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company's stock worth $89,944,000 after purchasing an additional 441,692 shares in the last quarter. Sea Cliff Partners Management LP bought a new stake in Acadia Healthcare during the 4th quarter valued at $26,338,000. Vaughan Nelson Investment Management L.P. purchased a new stake in shares of Acadia Healthcare during the fourth quarter worth $24,157,000. OFI Invest Asset Management boosted its holdings in shares of Acadia Healthcare by 290.5% in the third quarter. OFI Invest Asset Management now owns 331,129 shares of the company's stock worth $21,990,000 after acquiring an additional 246,322 shares during the period. Finally, Jennison Associates LLC grew its position in shares of Acadia Healthcare by 26.1% in the fourth quarter. Jennison Associates LLC now owns 1,148,755 shares of the company's stock valued at $89,327,000 after purchasing an additional 238,114 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.